The "majority" of the layoffs, according to the company, are at Catalent's manufacturing campus in Harmans, Maryland, which includes two facilities that support phase 3 through commercial production of gene therapies.
https://www.fiercepharma.com/manufacturing/catalent-lays-350-gene-therapy-manufacturing-facilities-maryland